Cheryl Buxton - Net Worth and Insider Trading

Cheryl Buxton Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cheryl Buxton owns 1 companies in total, including Humanigen Inc (HGENQ) .

Click here to see the complete history of Cheryl Buxton’s form 4 insider trades.

Insider Ownership Summary of Cheryl Buxton

Ticker Comapny Transaction Date Type of Owner
HGENQ Humanigen Inc 2019-12-16 director

Cheryl Buxton Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cheryl Buxton Ownership Network

Ownership Network List of Cheryl Buxton

No Data

Ownership Network Relation of Cheryl Buxton


Cheryl Buxton Owned Company Details

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Cheryl Buxton is the director of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

Over the past 18 months, Cheryl Buxton made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Humanigen Inc Insider Transactions

No Available Data

Cheryl Buxton Mailing Address

Above is the net worth, insider trading, and ownership report for Cheryl Buxton. You might contact Cheryl Buxton via mailing address: 533 Airport Blvd., Suite 400, Burlingame Ca 94010.

Discussions on Cheryl Buxton

No discussions yet.